Balaji Prasad
Stock Analyst at Barclays
(0.57)
# 2134
Out of 5,318 analysts
167
Total ratings
28.10%
Success rate
-9.91%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
EOLS Evolus | Maintains: Overweight | 22 25 | 10.1 | 147.52% | 8 | Mar 5, 2025 | |
AMRX Amneal Pharmaceutica... | Maintains: Overweight | 10 11 | 7.16 | 53.63% | 5 | Mar 3, 2025 | |
PCRX Pacira BioSciences | Maintains: Overweight | 17 24 | 24.46 | -1.88% | 9 | Feb 28, 2025 | |
VTRS Viatris | Maintains: Underweight | 12 9 | 7.39 | 21.79% | 8 | Feb 28, 2025 | |
JAZZ Jazz Pharmaceuticals | Maintains: Overweight | 190 200 | 101.69 | 96.68% | 7 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 20 19 | 8.13 | 133.7% | 13 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 62 60 | 49.39 | 21.48% | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 242 244 | 146.72 | 66.3% | 15 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 26 24 | 10.82 | 121.81% | 2 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 20 22 | 16.82 | 30.8% | 8 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 481 520 | 403.02 | 29.03% | 9 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 28 26 | 13.41 | 93.89% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 3 | n/a | n/a | 9 | Dec 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 150 160 | 103.6 | 54.44% | 15 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 18 17 | 13.43 | 26.58% | 13 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 22 18 | 8.3 | 116.87% | 5 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 8 7 | 1.01 | 593.07% | 7 | Oct 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 3 10 | 2.74 | 264.96% | 2 | Oct 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 3 2 | n/a | n/a | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 26 21 | n/a | n/a | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 2 1 | n/a | n/a | 3 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 10 | n/a | n/a | 4 | Aug 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 5 3 | n/a | n/a | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 8 | n/a | n/a | 1 | Mar 25, 2020 |